Delivery Order SPE2DB24D2216-SPE2DB25FGPLX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,041.98 to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (90-count units) on August 26, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,537.98 delivery order to AmerisourceBergen Drug Corp for 1,000 units of Synthroid 25 micrograms on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement under delivery order contract type. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the vendor is headquartered...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $50,535.07 delivery order on July 18, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. Performance will be completed by July 21, 2025, with fulfillment occurring at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.37 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units, with a ceiling value of $1,678.76. This non-competitive, firm fixed price delivery order is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $3,135.68 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,478.35, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,231.14 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 mcg. This firm fixed-price delivery order, issued on September 17, 2025, with completion targeted for September 18, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPLXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (1,000 count) under a firm fixed-price contract valued at $1,430.00. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in the same city. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen's contract portfolio with DLA demonstrates its established capability to fulfill federal medical procurement requirements across multiple therapeutic domains, serving defense healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/7/25 |